The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis
Global tuberculosis incidence has declined marginally over the past decade, and
tuberculosis remains out of control in several parts of the world including Africa and Asia …
tuberculosis remains out of control in several parts of the world including Africa and Asia …
Drug resistant Tuberculosis: A review
JL Khawbung, D Nath, S Chakraborty - … immunology, microbiology and …, 2021 - Elsevier
Tuberculosis (TB) was announced as a global emergency in 1993. There was an alarming
counter attack of TB worldwide. However, when it was known that TB can be cured …
counter attack of TB worldwide. However, when it was known that TB can be cured …
Treatment of drug-resistant tuberculosis. An official ATS/CDC/ERS/IDSA clinical practice guideline
Background: The American Thoracic Society, US Centers for Disease Control and
Prevention, European Respiratory Society, and Infectious Diseases Society of America …
Prevention, European Respiratory Society, and Infectious Diseases Society of America …
Drug-associated adverse events in the treatment of multidrug-resistant tuberculosis: an individual patient data meta-analysis
Background Treatment of multidrug-resistant tuberculosis requires long-term therapy with a
combination of multiple second-line drugs. These drugs are associated with numerous …
combination of multiple second-line drugs. These drugs are associated with numerous …
Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR-and XDR-TB: a multicentre study
SE Borisov, K Dheda, M Enwerem… - European …, 2017 - Eur Respiratory Soc
Large studies on bedaquiline used to treat multidrug-resistant (MDR-) and extensively drug-
resistant tuberculosis (XDR-TB) are lacking. This study aimed to evaluate the safety and …
resistant tuberculosis (XDR-TB) are lacking. This study aimed to evaluate the safety and …
Advances in the development of new tuberculosis drugs and treatment regimens
Despite the introduction 40 years ago of the inexpensive and effective four-drug (isoniazid,
rifampicin, pyrazinamide and ethambutol) treatment regimen, tuberculosis (TB) continues to …
rifampicin, pyrazinamide and ethambutol) treatment regimen, tuberculosis (TB) continues to …
[图书][B] WHO operational handbook on tuberculosis: module 4: treatment: drug-resistant tuberculosis treatment
World Health Organization - 2020 - apps.who.int
The World Health Organization (WHO) has produced this WHO operational handbook on
tuberculosis to provide practical advice to complement the latest WHO consolidated …
tuberculosis to provide practical advice to complement the latest WHO consolidated …
Therapeutic drug monitoring in the treatment of tuberculosis: an update
A Alsultan, CA Peloquin - Drugs, 2014 - Springer
Tuberculosis (TB) is the world's second leading infectious killer. Cases of multidrug-resistant
(MDR-TB) and extremely drug-resistant (XDR-TB) have increased globally. Therapeutic …
(MDR-TB) and extremely drug-resistant (XDR-TB) have increased globally. Therapeutic …
[HTML][HTML] Public health burden of antimicrobial resistance in Europe
E Tacconelli, MD Pezzani - The Lancet Infectious Diseases, 2019 - thelancet.com
Antimicrobial resistance is one of the greatest challenges of the 21st century. Evaluation of
the public health burden of antimicrobial resistance, which is needed to drive policy …
the public health burden of antimicrobial resistance, which is needed to drive policy …
Treatment of tuberculosis. A historical perspective
JF Murray, DE Schraufnagel… - Annals of the American …, 2015 - atsjournals.org
Of all achievements in medicine, the successful treatment of tuberculosis has had one of the
greatest impacts on society. Tuberculosis was a leading cause of disease and a mortal …
greatest impacts on society. Tuberculosis was a leading cause of disease and a mortal …